PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions
Jennifer Le Guévelou(Inserm), Thomas Zilli(University of Geneva), Paul Sargos, Vérane Achard(University of Geneva), Valentina Garibotto(University of Geneva), Ismini Mainta(University Hospital of Geneva), Habib Zaidi(University Medical Center Groningen), Cynthia Ménard(University of Toronto), I. Latorzeff(Clinique Pasteur)
Cited by 12
Related Papers
The Image Biomarker Standardization Initiative: Standardized Convolutional Filters for Reproducible Radiomics and Enhanced Clinical Insights
|Radiology|2024|210
Quantification of amyloid PET for future clinical use: a state-of-the-art review
|European Journal of Nuclear Medicine and Molecular Imaging|2022|208
Deep learning-assisted ultra-fast/low-dose whole-body PET/CT imaging
|European Journal of Nuclear Medicine and Molecular Imaging|2021|153
Advancements in brachytherapy
|Advanced Drug Delivery Reviews|2016|104
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
|Radiotherapy and Oncology|2022|98